⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IONS News
Ionis Pharmaceuticals, Inc. Common Stock
IONS Investor Alert: Levi & Korsinsky Notifies Investors of an Investigation Into Ionis Pharmaceuticals (IONS)
businesswire.com
IONS
Ionis doses first participant in Phase 1-2 ASCEND study of ION337 in Dravet syndrome
businesswire.com
IONS
Levi & Korsinsky Announces Investigation of Securities Claims Against Ionis Pharmaceuticals, Inc. (IONS)
accessnewswire.com
IONS
IONS SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Ionis Pharmaceuticals
prnewswire.com
IONS
Form 8-K
sec.gov
IONS
Ionis Pharmaceuticals Investigation Notice: Levi & Korsinsky Notifies Investors of a Pending Investigation Into Ionis Pharmaceuticals (IONS)
prnewswire.com
IONS
Form 8-K
sec.gov
IONS
Update on CARDIO-TTRansform Phase 3 trial of eplontersen in adults with transthyretin-mediated amyloid cardiomyopathy
businesswire.com
IONS
Transthyretin Amyloidosis Treatment Market Size to Reach USD 35.10 Billion by 2035, Growing at a 14.64% CAGR | SNS Insider
globenewswire.com
ALNY
BIIB
PFE
IONS
Ionis completes enrollment in pivotal cohort of the Phase 3 REVEAL study evaluating obudanersen in Angelman syndrome
businesswire.com
IONS